Production of placental CRH, which is identical to the peptide synthesized
and secreted in the hypothalamus, has been linked to human parturition. Glu
cocorticoids stimulate placental CRH secretion and messenger ribonucleic ac
id expression, in contrast to their inhibition of CRH synthesis in the hypo
thalamus. A positive feedforward loop involving glucocorticoid-CRH-ACTH-glu
cocorticoid is thought to drive the exponential increase in placental CRH l
eading to delivery. Tissue-specific effects of glucocorticoids on CRH expre
ssion are therefore of interest. Using human primary placental cells, we in
vestigated the mechanism by which glucocorticoids stimulate placental CRH g
ene expression. Nuclear run-on transcription shows that in human placental
cells glucocorticoids up-regulate transcription of human CRH (hCRH). Using
transient transfection assays we demonstrate that dexamethasone up-regulate
s both basal and cAMP-stimulated hCRH promoter activity, correlating well w
ith the increase in endogenous CRH peptide levels. Through mutagenesis and
deletion analyses we show that dexamethasone stimulation of hCRH gene trans
cription requires a functional cAMP regulatory element (CRE); this CRE is a
dequate to confer dexamethasone stimulation upon a heterologous promoter, a
nd electrophoretic mobility shift assay studies show that a placental nucle
ar protein specifically binds to the hCRH CRE.